Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5272215
Max Phase: Preclinical
Molecular Formula: C84H149N13O14S
Molecular Weight: 1597.26
Associated Items:
ID: ALA5272215
Max Phase: Preclinical
Molecular Formula: C84H149N13O14S
Molecular Weight: 1597.26
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCCCC(=O)N[C@@H](CSCC(COC(=O)CCCCCCCCCCCCCCC)OC(=O)CCCCCCCCCCCCCCC)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C84H149N13O14S/c1-4-7-10-13-16-19-22-25-28-31-34-37-40-49-73(99)92-71(63-112-62-66(111-76(103)51-42-39-36-33-30-27-24-21-18-15-12-9-6-3)61-110-75(102)50-41-38-35-32-29-26-23-20-17-14-11-8-5-2)80(107)94-68(47-44-57-91-84(88)89)82(109)97-58-45-48-72(97)81(108)96-70(60-74(100)101)79(106)93-67(46-43-56-90-83(86)87)78(105)95-69(77(85)104)59-64-52-54-65(98)55-53-64/h52-55,66-72,98H,4-51,56-63H2,1-3H3,(H2,85,104)(H,92,99)(H,93,106)(H,94,107)(H,95,105)(H,96,108)(H,100,101)(H4,86,87,90)(H4,88,89,91)/t66?,67-,68-,69-,70-,71-,72-/m0/s1
Standard InChI Key: IFMFAVGIXFHDEH-GFPBKZJXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1597.26 | Molecular Weight (Monoisotopic): 1596.1068 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Kaur A, Kaushik D, Piplani S, Mehta SK, Petrovsky N, Salunke DB.. (2021) TLR2 Agonistic Small Molecules: Detailed Structure-Activity Relationship, Applications, and Future Prospects., 64 (1.0): [PMID:33346636] [10.1021/acs.jmedchem.0c01627] |
Source(1):